Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
Products
API & Intermediates
Cell Signaling Pathway Inhibitors
Small Molecule Compounds
Impurity Reference Standards
·Imatinib Series
·Gefitinib Series
·Afatinib Series
·Valsartan Series
·Hydrochlorothiazide Series
·Alogliptin Benzoate impurity
Others
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Impurity Reference Standards Now Position:Home > Products > Impurity Reference Standards < Afatinib Series
(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)but-2-enamide(CAS:N.A)

 

Product No.

TP1005DZ01

Name

(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)but-2-enamide

Structure

Formula

C22H20ClFN4O3

Mol. Wt.

442.87

CAS Number

N.A

Purity

>99%

Package

5mg, 10mg, 20mg, 50mg





Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan